The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...
A new study published in Engineering has identified enolase 2 (ENO2) as a key factor in the lymphatic metastasis of head and ...
News Medical on MSN5d
ENO2 Crucial in Head, Neck Cancer MetastasisA recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck ...
As of December 31, 2024, Fortress' consolidated cash and cash equivalents totaled $57.3 million, compared to $58.9 million as ...
Neoadjuvant chemoimmunotherapy is associated with significantly improved survival outcomes compared with standard ...
EMA committee recommends approval of Bristol Myers Squibb’s subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Monday, March 31, ...
HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCCUpdated data from ongoing Phase 1/1b trial in 1L ...
BioAtla is extending its runway beyond key clinical readouts in 1H 2026 by restructuring and realigning resources, which ...
Expression data from patient-derived xenograft (PDX) mouse models exposed to micvotabart pelidotin (MICVO) indicate gene signatures associated ...
Discover why Immutep's Eftilagimod Alpha shows promise in NSCLC and HNSCC trials, but cautious investment is advised. Explore more details here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback